EGFR methylation and outcome of patients with advanced colorectal cancer treated with cetuximab

By  

Oncology Letters, Vol. 9, Iss. 3, 2015-01 ,pp. : 1432-1438

Spandidos Publications

Access to resources Recommend Favorite

Phase I clinical trial of the anti-EGFR monoclonal antibody nimotuzumab with concurrent external thoracic radiotherapy in Canadian patients diagnosed with stage IIb, III or IV non-small cell lung cancer unsuitable for radical therapy

By Bebb Gwyn   Smith Colum   Rorke Stewart   Boland William   Nicacio Leonardo   Sukhoo Ryan   Brade Anthony  

Cancer Chemotherapy and Pharmacology, Vol. 67, Iss. 4, 2011-04 ,pp. : 837-845

Springer Publishing Company

Access to resources Recommend Favorite

Multiple Infusions of Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody (EMD 55 900) in Patients with Recurrent Malignant Gliomas

By Stragliotto G.   Vega F.   Stasiecki P.   Gropp P.   Poisson M.   Delattre J.-Y.  

European Journal of Cancer, Vol. 32, Iss. 4, 1996-04 ,pp. : 636-640

Elsevier

Access to resources Recommend Favorite

A Phase II trial of paclitaxel and topotecan with filgrastim in patients with recurrent or refractory glioblastoma multiforme or anaplastic astrocytoma

By Pipas J.   Meyer Louise   Rhodes C.   Cromwell Laurence   McDonnell Carol   Kingman Linda   Rigas James   Fadul Camilo  

Journal of Neuro-Oncology, Vol. 71, Iss. 3, 2005-02 ,pp. : 301-305

Springer Publishing Company

Access to resources Recommend Favorite

Phase I pilot clinical trial of human IgM monoclonal antibody to ganglioside GM3 in patients with metastatic melanoma

By Irie Reiko   Ollila David   O’Day Steven   Morton Donald  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 2, 2004-02 ,pp. : 110-117

Springer Publishing Company

Access to resources Recommend Favorite